Back to search

Article

Programming T cells for Early Cancer Detection with Customized Protease-Activatable Receptors

2026-01-20

Abstract excerpt

Early cancer detection has the potential to reduce cancer mortality, yet endogenous tumor-shed biomarkers lack sensitivity for early-stage disease. We report OncoSCOUT, a cancer detection strategy using T cells engineered with protease-activatable receptors (PARs) that conditionally recognize tumor cells and release a synthetic biomarker for detection in urine. These PARs comprise masked synthetic Notch receptors...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
73fc3e7c-3993-5013-b9fc-c4ed46078b62
DOI
10.64898/2026.01.16.699939
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Programming T cells for Early Cancer Detection with Customized Protease-Activatable ReceptorsDOI 10.64898/2026.01.16.699939
Select a neighboring publication to make it the new centre.